Literature DB >> 32678272

Mycobacterium tuberculosis-specific CD4 T cells expressing CD153 inversely associate with bacterial load and disease severity in human tuberculosis.

Robert J Wilkinson1,2,3,4, Catherine Riou5,6, Elsa Du Bruyn7, Sheena Ruzive7, Cecilia S Lindestam Arlehamn8, Alessandro Sette8,9, Alan Sher10, Daniel L Barber11.   

Abstract

Recent data from mice and non-human primate models of tuberculosis suggested that CD153, a TNF super family member, plays an important role in Mycobacterium tuberculosis (Mtb) control. However, this molecule has not been comprehensively evaluated in humans. Here, we show that the proportion of Mtb-specific CD4 T cells expressing CD153 was significantly reduced in active TB patients compared to latently infected persons. Importantly, the CD153+ Mtb-specific CD4 response inversely correlated with lung bacterial load, inferred by Xpert cycle threshold, irrespective of HIV status. Antitubercular treatment partially restored CD153 expression on Mtb-specific CD4 T cells. This is the first report of a subset of Mtb-specific CD4 T cells showing strong negative correlation with bacterial burden. Building on substantial evidence from animal models implicating CD153 as a mediator of host protection, our findings suggest it may play a similar role in humans and its measurement may be useful to evaluate TB vaccine efficacy.

Entities:  

Year:  2020        PMID: 32678272      PMCID: PMC7855386          DOI: 10.1038/s41385-020-0322-6

Source DB:  PubMed          Journal:  Mucosal Immunol        ISSN: 1933-0219            Impact factor:   7.313


  45 in total

1.  A multisite assessment of the quantitative capabilities of the Xpert MTB/RIF assay.

Authors:  Robert Blakemore; Pamela Nabeta; Amy L Davidow; Viral Vadwai; Rasim Tahirli; Vanisha Munsamy; Mark Nicol; Martin Jones; David H Persing; Doris Hillemann; Sabine Ruesch-Gerdes; Felicity Leisegang; Carlos Zamudio; Camilla Rodrigues; Catharina C Boehme; Mark D Perkins; David Alland
Journal:  Am J Respir Crit Care Med       Date:  2011-11-01       Impact factor: 21.405

2.  T Cells and Tuberculosis: Beyond Interferon-gamma.

Authors:  Ajit Lalvani; Kerry A Millington
Journal:  J Infect Dis       Date:  2008-04-01       Impact factor: 5.226

3.  Evaluation of the Xpert MTB/RIF assay for the diagnosis of pulmonary tuberculosis in a high HIV prevalence setting.

Authors:  Grant Theron; Jonny Peter; Richard van Zyl-Smit; Hridesh Mishra; Elizabeth Streicher; Samuel Murray; Rodney Dawson; Andrew Whitelaw; Michael Hoelscher; Surendra Sharma; Madhukar Pai; Robin Warren; Keertan Dheda
Journal:  Am J Respir Crit Care Med       Date:  2011-04-14       Impact factor: 21.405

Review 4.  The Immune Response to Mycobacterium tuberculosis in HIV-1-Coinfected Persons.

Authors:  Hanif Esmail; Catherine Riou; Elsa du Bruyn; Rachel Pei-Jen Lai; Yolande X R Harley; Graeme Meintjes; Katalin A Wilkinson; Robert J Wilkinson
Journal:  Annu Rev Immunol       Date:  2018-02-28       Impact factor: 28.527

5.  IL-21 signaling is essential for optimal host resistance against Mycobacterium tuberculosis infection.

Authors:  Matthew G Booty; Palmira Barreira-Silva; Stephen M Carpenter; Cláudio Nunes-Alves; Miye K Jacques; Britni L Stowell; Pushpa Jayaraman; Gillian Beamer; Samuel M Behar
Journal:  Sci Rep       Date:  2016-11-07       Impact factor: 4.379

Review 6.  Type I interferons in tuberculosis: Foe and occasionally friend.

Authors:  Lúcia Moreira-Teixeira; Katrin Mayer-Barber; Alan Sher; Anne O'Garra
Journal:  J Exp Med       Date:  2018-04-17       Impact factor: 17.579

Review 7.  Cell Differentiation Degree as a Factor Determining the Role for Different T-Helper Populations in Tuberculosis Protection.

Authors:  Irina Lyadova; Irina Nikitina
Journal:  Front Immunol       Date:  2019-05-08       Impact factor: 7.561

8.  Host resistance to pulmonary Mycobacterium tuberculosis infection requires CD153 expression.

Authors:  Michelle A Sallin; Keith D Kauffman; Catherine Riou; Elsa Du Bruyn; Taylor W Foreman; Shunsuke Sakai; Stella G Hoft; Timothy G Myers; Paul J Gardina; Alan Sher; Rashida Moore; Temeri Wilder-Kofie; Ian N Moore; Alessandro Sette; Cecilia S Lindestam Arlehamn; Robert J Wilkinson; Daniel L Barber
Journal:  Nat Microbiol       Date:  2018-09-10       Impact factor: 17.745

9.  An essential role for interferon gamma in resistance to Mycobacterium tuberculosis infection.

Authors:  J L Flynn; J Chan; K J Triebold; D K Dalton; T A Stewart; B R Bloom
Journal:  J Exp Med       Date:  1993-12-01       Impact factor: 14.307

10.  Prevention of tuberculosis in macaques after intravenous BCG immunization.

Authors:  Mario Roederer; JoAnne L Flynn; Robert A Seder; Patricia A Darrah; Joseph J Zeppa; Pauline Maiello; Joshua A Hackney; Marc H Wadsworth; Travis K Hughes; Supriya Pokkali; Phillip A Swanson; Nicole L Grant; Mark A Rodgers; Megha Kamath; Chelsea M Causgrove; Dominick J Laddy; Aurelio Bonavia; Danilo Casimiro; Philana Ling Lin; Edwin Klein; Alexander G White; Charles A Scanga; Alex K Shalek
Journal:  Nature       Date:  2020-01-01       Impact factor: 49.962

View more
  10 in total

1.  Mucosal Vaccination with Cyclic Dinucleotide Adjuvants Induces Effective T Cell Homing and IL-17-Dependent Protection against Mycobacterium tuberculosis Infection.

Authors:  Robyn M Jong; Erik Van Dis; Samuel B Berry; Xammy Nguyenla; Alexander Baltodano; Gabrielle Pastenkos; Chenling Xu; Douglas Fox; Nir Yosef; Sarah M McWhirter; Sarah A Stanley
Journal:  J Immunol       Date:  2021-12-29       Impact factor: 5.422

Review 2.  Tuberculosis Treatment Monitoring and Outcome Measures: New Interest and New Strategies.

Authors:  Jan Heyckendorf; Sophia B Georghiou; Nicole Frahm; Norbert Heinrich; Irina Kontsevaya; Maja Reimann; David Holtzman; Marjorie Imperial; Daniela M Cirillo; Stephen H Gillespie; Morten Ruhwald
Journal:  Clin Microbiol Rev       Date:  2022-03-21       Impact factor: 50.129

3.  Mycobacterium tuberculosis Immune Response in Patients With Immune-Mediated Inflammatory Disease.

Authors:  Elisa Petruccioli; Linda Petrone; Teresa Chiacchio; Chiara Farroni; Gilda Cuzzi; Assunta Navarra; Valentina Vanini; Umberto Massafra; Marianna Lo Pizzo; Giuliana Guggino; Nadia Caccamo; Fabrizio Cantini; Fabrizio Palmieri; Delia Goletti
Journal:  Front Immunol       Date:  2021-08-10       Impact factor: 7.561

4.  A virtual host model of Mycobacterium tuberculosis infection identifies early immune events as predictive of infection outcomes.

Authors:  Louis R Joslyn; Jennifer J Linderman; Denise E Kirschner
Journal:  J Theor Biol       Date:  2022-01-31       Impact factor: 2.405

5.  Comprehensive analysis of mycobacterium tuberculosis antigen-specific CD4+ T cell responses restricted by single HLA class II allotype in an individual.

Authors:  Yong-Hun Lee; You-Seok Hyun; Hyeong-A Jo; In-Cheol Baek; Sun-Mi Kim; Hyun-Jung Sohn; Tai-Gyu Kim
Journal:  Front Immunol       Date:  2022-07-28       Impact factor: 8.786

Review 6.  Immune evasion and provocation by Mycobacterium tuberculosis.

Authors:  Pallavi Chandra; Steven J Grigsby; Jennifer A Philips
Journal:  Nat Rev Microbiol       Date:  2022-07-25       Impact factor: 78.297

7.  IFN-γ-independent control of M. tuberculosis requires CD4 T cell-derived GM-CSF and activation of HIF-1α.

Authors:  Erik Van Dis; Douglas M Fox; Huntly M Morrison; Daniel M Fines; Janet Peace Babirye; Lily H McCann; Sagar Rawal; Jeffery S Cox; Sarah A Stanley
Journal:  PLoS Pathog       Date:  2022-07-25       Impact factor: 7.464

8.  GPX4 regulates cellular necrosis and host resistance in Mycobacterium tuberculosis infection.

Authors:  Eduardo P Amaral; Taylor W Foreman; Sivaranjani Namasivayam; Kerry L Hilligan; Keith D Kauffman; Caio Cesar Barbosa Bomfim; Diego L Costa; Beatriz Barreto-Duarte; Clarissa Gurgel-Rocha; Monique Freire Santana; Marcelo Cordeiro-Santos; Elsa Du Bruyn; Catherine Riou; Kate Aberman; Robert John Wilkinson; Daniel L Barber; Katrin D Mayer-Barber; Bruno B Andrade; Alan Sher
Journal:  J Exp Med       Date:  2022-09-07       Impact factor: 17.579

9.  HLA-DR Marks Recently Divided Antigen-Specific Effector CD4 T Cells in Active Tuberculosis Patients.

Authors:  Rashmi Tippalagama; Akul Singhania; Paige Dubelko; Cecilia S Lindestam Arlehamn; Austin Crinklaw; Mikhail Pomaznoy; Gregory Seumois; Aruna D deSilva; Sunil Premawansa; Dhammika Vidanagama; Bandu Gunasena; N D Suraj Goonawardhana; Dinuka Ariyaratne; Thomas J Scriba; Robert H Gilman; Mayuko Saito; Randy Taplitz; Pandurangan Vijayanand; Alessandro Sette; Bjoern Peters; Julie G Burel
Journal:  J Immunol       Date:  2021-06-30       Impact factor: 5.422

10.  Eosinophils are part of the granulocyte response in tuberculosis and promote host resistance in mice.

Authors:  Andrea C Bohrer; Ehydel Castro; Zhidong Hu; Artur T L Queiroz; Claire E Tocheny; Maike Assmann; Shunsuke Sakai; Christine Nelson; Paul J Baker; Hui Ma; Lin Wang; Wen Zilu; Elsa du Bruyn; Catherine Riou; Keith D Kauffman; Ian N Moore; Franca Del Nonno; Linda Petrone; Delia Goletti; Adrian R Martineau; David M Lowe; Mark R Cronan; Robert J Wilkinson; Clifton E Barry; Laura E Via; Daniel L Barber; Amy D Klion; Bruno B Andrade; Yanzheng Song; Ka-Wing Wong; Katrin D Mayer-Barber
Journal:  J Exp Med       Date:  2021-08-04       Impact factor: 14.307

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.